Year: 2026
Type: preprint
Abstract: Autophagy is a highly conserved cellular mechanism essential for recycling intracellular components and providing energy and maintaining cellular homeostasis. The role of autophagy in cancer is double sided, where it can suppress tumorigenesis by degrading damaged organelles and preventing chronic inflammation while supporting survival of existing tumor cells to survive during starvation and stress, and thus support tumor growth. The role of autophagy in renal cell carcinoma (RCC), the most common type of kidney cancer, remains insufficiently described. RCC originates from epithelial cells of the renal tubule and is divided into histological subtypes where clear cell RCC is the most common followed by papillary and chromophobe RCC, showing differences in morphology and molecular features. Recent studies of RCC suggest that mTORC1 and autophagy are involved in kidney cancer development and response to treatment, advocating the need to better understand the role of autophagy in RCC. To this end, we investigated autophagy markers by immunostaining, immunoblotting and quantitative PCR in biobanked fresh-frozen tissue samples of RCC tumor and matched normal tissue. Overall, we found reduced levels of LC3B and GABARAPL1 in clear cell RCC, in stark contrast to chromophobe RCC and benign oncocytoma. This suggests that autophagy levels differ between renal tumor subtypes, indicating that autophagy could play subtype-specific roles. In addition, autophagy modulating drug assays demonstrated autophagy dependencies in metastatic RCC cell line spheroids. This could provide new inroads for therapeutical approaches in RCC.
Authors: Feyza Kasikci(Formal analysis, Investigation, Visualization, Writing – original draft, Writing – review & editing), Julie Aarmo Johannessen(Formal analysis, Investigation, Visualization, Writing – original draft, Writing – review & editing), Eva Bassols-Citores(Formal analysis, Visualization, Writing – original draft, Writing – review & editing), Maria Frison(Investigation, Writing – review & editing), Siri Andresen(Investigation, Writing – review & editing), Elise Komttebed(Investigation, Writing – review & editing), Frode S. Nilsen(Resources, Writing – review & editing), Stig Müller(Resources, Writing – review & editing), Karol Axcrona(Resources, Writing – review & editing), Leiv Rønneberg(Supervision, Writing – review & editing), Manuela Zucknick(Supervision, Writing – review & editing), Lorant Farkas(Formal analysis, Investigation, Resources, Visualization, Writing – review & editing), Jorrit M. Enserink(Supervision, Writing – review & editing), Helene Knævelsrud(Conceptualization, Formal analysis, Funding acquisition, Investigation, Project administration, Supervision, Writing – original draft, Writing – review & editing)
Language: English
Subfield: Cell Biology
Domain: Life Sciences
Open Access status: green
Awards: G1014679103, G1145894853, G1158369970, G2328988699, G2389227461, Large-area Organic and Hybrid Solar Cells, G3031516843, G3967432015, G4178995775, G424848710, G4285542155, RESISTANCE UNDER COMBINATORIAL TREATMENT IN ER+ AND ER- BREAST CANCER., G514945525, G5259773219, G5938650868, G6230047823, G6859082763, G7087038653, G7651474627, G8998816634
OpenAlex ID: W7236677195
